Oracle (ORCL) director discloses sale of 2,223 company shares

Rhea-AI Filing Summary

Oracle Corp director Naomi O. Seligman reported selling 2,223 shares of Oracle common stock at a price of $196.61 per share on 12/23/2025. After this transaction, she beneficially owned 25,596 shares directly, 6,000 shares indirectly through her spouse, and 14,414 shares indirectly through a trust. The filing indicates this was a routine insider transaction reported by a single reporting person.

Insider Trade Summary

Net Seller: 2,223 shares

Net Sell 3 txns

Insider SELIGMAN NAOMI O

Role Director

Sold 2,223 shs ($437K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,223	$196.61	$437K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 25,596 shares (Direct); Common Stock — 6,000 shares (Indirect, By Spouse); Common Stock — 14,414 shares (Indirect, By Trust)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/23/2025 - 07:11 PM Learn about SEC filing dates

FAQ

What insider transaction did Oracle (ORCL) disclose in this filing?

The filing reports that director Naomi O. Seligman sold 2,223 shares of Oracle common stock on 12/23/2025 at a price of $196.61 per share.

What is Naomi O. Seligman’s role at Oracle (ORCL)?

Naomi O. Seligman is listed as a Director of Oracle Corp in this insider ownership report.

How many Oracle (ORCL) shares does Naomi O. Seligman own after the reported sale?

After the sale, she beneficially owned 25,596 shares directly, 6,000 shares indirectly through her spouse, and 14,414 shares indirectly through a trust.

Was this Oracle (ORCL) insider transaction reported by more than one person?

No. The form indicates it was filed by one reporting person, reflecting Naomi O. Seligman’s holdings and transaction.

What type of security was involved in the Oracle (ORCL) insider sale?

The transaction involved Oracle Corp common stock, reported under Table I for non-derivative securities.

Does this Oracle (ORCL) filing show any derivative securities transactions?

Table II for derivative securities is included in the form layout, but no specific derivative security transactions are listed in the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SELIGMAN NAOMI O

(Last) (First) (Middle)

C/O DELPHI ASSET MGMT CORPORATION

200 S. VIRGINIA ST., SUITE 625

(Street)

RENO NV 89501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/23/2025		S		2,223	D	$196.61	25,596	D
Common Stock								6,000	I	By Spouse
Common Stock								14,414	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Naomi O. Seligman (POA filed 6/4/19)	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.